Result Summary for 105818
| Protocol ID: | 105818 |
| Clinical Study ID: | 105818 |
| Official Title: | A post-marketing surveillance (PMS) study to monitor the safety of Naramig (Naratriptan) administered in Korean subjects according to the prescribing information. |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | naratriptan |
| Trade/Product Name: | Naragran,Amerge,Naramig |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
